Insights on Patient-Focused Drug Development (PFDD) OUR INSIGHTS LEARN MORE Contact Us We share our insights to keep you updated on patient engagement initiatives, trends, and regulatory guidelines Down arrow icon

OUR INSIGHTS

The hassle of interviewing patients in clinical trials without standardised procedures
Laura Lassen
Posted by Laura Lassen
February 15, 2021

The hassle of interviewing patients in clinical trials without standardised procedures

Ensuring that internal procedures are well in place is important for any company as it helps assuring the quality of its products and/or services. In terms of this, pharmaceutical companies...

Read More
Improving the retention of patients in clinical trials
Laura Lassen
Posted by Laura Lassen
January 29, 2021

Improving the retention of patients in clinical trials

Insufficient patient retention in clinical trials is a common issue in the pharmaceutical industry. It has a number of consequences for the drug development...

Read More
Online trial investigator result meetings - what about the investigators’ feedback?
Laura Lassen
Posted by Laura Lassen
January 22, 2021

Online trial investigator result meetings - what about the investigators’ feedback?

Following the outbreak of the COVID-19 pandemic, we now see that investigator result meetings have changed their format to online interaction...

Read More
Generating early insights on investigational drug
Jens Harald Kongsø
Posted by Jens Harald Kongsø
January 7, 2021

The value of generating early insights on your investigational drug

When pharmaceutical companies develop new medicines, they are required to comply with regulatory requirements by reporting and publishing their clinical results. Adhering to these...

Read More
Informing trial patients on the clinical trial results
Laura Lassen
Posted by Laura Lassen
December 30, 2020

Are you properly informing your trial patients on the clinical trial results?

The importance of keeping your trial patients well-informed. True patient-centricity is not only obtaining input from trial patients – it also involves ...

Read More
Patient and Public Involvement (PPI)
Laura Lassen
Posted by Laura Lassen
December 18, 2020

Initiatives facilitating the advancement of Patient and Public Involvement in drug development

Patient and Public Involvement (PPI) can improve clinical research success. PPI is defined as research that is carried out with or by patients and those who have experience of a condition...

Read More